• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度的干细胞移植。

Stem cell transplantation in India.

作者信息

Chandy M

机构信息

Hematology Department, The Christian Medical College, Vellore, India.

出版信息

Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S81-S84. doi: 10.1038/bmt.2008.124.

DOI:10.1038/bmt.2008.124
PMID:18724312
Abstract

This paper outlines the BMT activity in India and describes in some detail the transplant program at the Christian Medical College, Vellore. In September 2005, data from six transplant centers in India were collected and a total of 1540 transplants have been performed in a country of over one billion population. At the center in Vellore, from October 1986 to December 2006, a total of 626 transplants have been performed in 595 patients, with 28 patients having more than one transplant. Thalassemia accounted for a third of these transplants: the country has over 20 million carriers and 10,000 children are born each year with thalassemia major. The average cost of allogeneic BMT in India is around $15,000-20,000, and this is considerably lower than the cost in the West. India needs to develop more transplant centers with adequately trained personnel, as there is great need for them. Improvements in the economy mean that more patients can afford this treatment.

摘要

本文概述了印度的骨髓移植活动,并详细介绍了位于韦洛尔的基督教医学院的移植项目。2005年9月,收集了印度六个移植中心的数据,在这个人口超过十亿的国家,总共进行了1540例移植手术。在韦洛尔的中心,从1986年10月到2006年12月,共对595名患者进行了626例移植手术,其中28名患者接受了不止一次移植。地中海贫血占这些移植手术的三分之一:该国携带地中海贫血基因的人数超过2000万,每年有10000名重型地中海贫血患儿出生。印度异基因骨髓移植的平均费用约为15000 - 20000美元,这比西方的费用要低得多。印度需要发展更多配备训练有素人员的移植中心,因为对此有巨大需求。经济的改善意味着更多患者能够负担得起这种治疗。

相似文献

1
Stem cell transplantation in India.印度的干细胞移植。
Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S81-S84. doi: 10.1038/bmt.2008.124.
2
Hematopoietic stem cell transplantation in Oman.阿曼的造血干细胞移植
Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S109-S113. doi: 10.1038/bmt.2008.131.
3
Hematopoietic stem cell transplantation in thalassemia.地中海贫血的造血干细胞移植
Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S41. doi: 10.1038/bmt.2008.112.
4
The stem cell transplant program in Pakistan--the first decade.巴基斯坦的干细胞移植项目——首个十年
Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S114-S117. doi: 10.1038/bmt.2008.137.
5
Bone marrow and stem cell transplantation at King Hussein cancer center.侯赛因国王癌症中心的骨髓与干细胞移植
Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S89-S91. doi: 10.1038/bmt.2008.126.
6
Hematopoietic stem cell transplantation in Egypt.埃及的造血干细胞移植
Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S76-S80. doi: 10.1038/bmt.2008.136.
7
Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.异基因干细胞移植治疗成人骨髓增生异常综合征:移植前疾病负担的重要性。
Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8. doi: 10.1016/j.bbmt.2008.10.012.
8
Stem cell transplantation programme at Singapore General Hospital.新加坡总医院的干细胞移植项目。
Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S121-S124. doi: 10.1038/bmt.2008.139.
9
Safety of hematopoietic stem cell transplantation in children less than three years of age.
Pediatr Hematol Oncol. 2008 Dec;25(8):705-22. doi: 10.1080/08880010802243524.
10
The activity of hematopoietic stem cell transplantation in Korea.韩国造血干细胞移植的活动情况。
Bone Marrow Transplant. 2008 Aug;42 Suppl 1:S92-S95. doi: 10.1038/bmt.2008.127.

引用本文的文献

1
Red cell Alloimmunization and its Correlation with Clinical Spectrum & Transfusion Profile in Pediatric Thalassemia Major Patients: Experience from a Tertiary Care Pediatric Center in Northern India.重型小儿地中海贫血患者的红细胞同种免疫及其与临床谱和输血情况的相关性:来自印度北部一家三级护理儿科中心的经验
Indian J Hematol Blood Transfus. 2025 Apr;41(2):298-305. doi: 10.1007/s12288-024-01831-w. Epub 2024 Aug 6.
2
Red cell alloimmunization and associated risk factors in multiply transfused thalassemia patients: A prospective cohort study conducted at a tertiary care center in Northern India.多次输血的地中海贫血患者的红细胞同种免疫及相关危险因素:在印度北部一家三级护理中心进行的一项前瞻性队列研究。
Asian J Transfus Sci. 2023 Jul-Dec;17(2):145-150. doi: 10.4103/ajts.ajts_2_23. Epub 2023 May 11.
3
Hematopoietic cell transplantation landscape in India.印度造血细胞移植的现状
Med J Armed Forces India. 2023 Nov-Dec;79(6):621-630. doi: 10.1016/j.mjafi.2023.09.002. Epub 2023 Sep 13.
4
Idiopathic Aplastic anemia: Indian Perspective.特发性再生障碍性贫血:印度视角
Indian J Hematol Blood Transfus. 2023 Jul;39(3):357-370. doi: 10.1007/s12288-022-01592-4. Epub 2022 Oct 31.
5
Novel genetic therapeutic approaches for modulating the severity of β-thalassemia (Review).用于调节β地中海贫血严重程度的新型基因治疗方法(综述)
Biomed Rep. 2020 Nov;13(5):48. doi: 10.3892/br.2020.1355. Epub 2020 Sep 2.
6
Development of a clinical hematology and stem cell transplantation program to provide state-of-the-art and cost-effective treatment to patients: a successful collaboration between a medical college in India and a leading medical university in the United States.开展临床血液学和干细胞移植项目,为患者提供最先进且具成本效益的治疗:印度一所医学院与美国一所顶尖医科大学之间的成功合作。
Blood Adv. 2019 Dec 6;3(Suppl 1):23-26. doi: 10.1182/bloodadvances.2019GS121428.
7
A guide to organize voluntary stem cell donors recruitment drive for hematopoietic progenitor stem cell transplant.造血祖细胞干细胞移植自愿干细胞捐献者招募活动组织指南。
Asian J Transfus Sci. 2019 Jan-Jun;13(1):39-42. doi: 10.4103/ajts.AJTS_145_18.
8
Matched unrelated donor hematopoietic progenitor cell transplantation: A report based on a single registry in India.匹配无关供者造血祖细胞移植:基于印度单一登记处的报告。
Leuk Res Rep. 2019 Mar 13;11:17-20. doi: 10.1016/j.lrr.2019.03.003. eCollection 2019.
9
Access to hematopoietic stem-cell transplantation in India.印度造血干细胞移植的可及性。
J Postgrad Med. 2019 Jan-Mar;65(1):1-4. doi: 10.4103/jpgm.JPGM_391_18.
10
Hematopoietic Stem Cell Transplantation in India-2017 Annual Update.2017年印度造血干细胞移植年度更新
Indian J Hematol Blood Transfus. 2018 Jan;34(1):5-7. doi: 10.1007/s12288-017-0906-9. Epub 2017 Dec 1.